0.3721
Milestone Scientific Inc. stock is traded at $0.3721, with a volume of 163.64K.
It is down -2.85% in the last 24 hours and up +15.74% over the past month.
Milestone Scientific, Inc. develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States and internationally. The company operates through dental and medical segments. Its products include CompuDent System used to control the flow rate of the anesthesia during the injection that allows virtually painless injections for various dental procedures, including routine fillings, implants, root canals, and crowns; and CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances. CompuFlo also includes a disposable injection handpiece for the tactile control during the injection; CompuFlo Epidural, a computer controlled anesthesia system for use in various medical applications; CompuFlo Intra-Articular, a computer controlled injection system for administering corticosteroids and other medicaments; CompuMed for use in various applications, such as plastic, hair restoration, podiatry, colorectal, dermatology, orthopedics, and various other surgeries. Its products also comprising Cosmetic Botulinum Injection device for the pain free injection of botulinum toxin; Veterinary Nerve Block Anesthesia device; the Wand Single Tooth Anesthesia System; and other devices. Milestone Scientific, Inc. was founded in 1989 and is headquartered in Livingston, New Jersey.
See More
Previous Close:
$0.383
Open:
$0.3737
24h Volume:
163.64K
Relative Volume:
0.09
Market Cap:
$32.77M
Revenue:
$8.97M
Net Income/Loss:
$-5.72M
P/E Ratio:
-5.3081
EPS:
-0.0701
Net Cash Flow:
$-2.93M
1W Performance:
+7.23%
1M Performance:
+15.74%
6M Performance:
+22.85%
1Y Performance:
-62.60%
Milestone Scientific Inc. Stock (MLSS) Company Profile
Name
Milestone Scientific Inc.
Sector
Industry
Phone
973-535-2717
Address
220 South Orange Avenue, Livingston, NJ
Compare MLSS vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
MLSS
Milestone Scientific Inc.
|
0.3721 | 33.73M | 8.97M | -5.72M | -2.93M | -0.0701 |
|
ISRG
Intuitive Surgical Inc
|
436.64 | 155.16B | 10.58B | 3.00B | 2.83B | 8.2437 |
|
BDX
Becton Dickinson Co
|
147.75 | 40.68B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
67.70 | 33.06B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
36.16 | 31.30B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
RMD
Resmed Inc
|
207.98 | 30.18B | 5.54B | 1.52B | 1.74B | 10.37 |
Milestone Scientific Inc. Stock (MLSS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-16-20 | Initiated | Northland Capital | Market Perform |
| Nov-16-18 | Reiterated | Maxim Group | Buy |
| Dec-23-16 | Reiterated | Maxim Group | Buy |
| Dec-11-15 | Initiated | Maxim Group | Buy |
Milestone Scientific Inc. Stock (MLSS) Latest News
Milestone Scientific (MLSS) Q1 2026 Earnings: Narrower Loss Beats Estimates as Stock Edges LowerOpen Signal Network - Newser
Benchmark reiterates Milestone Scientific stock rating on revenue guidance By Investing.com - Investing.com Nigeria
Benchmark reiterates Milestone Scientific stock rating on revenue guidance - Investing.com
Milestone Scientific (MLSS) price target decreased by 50.00% to 1.02 - MSN
Milestone Scientific, Inc. Common Stock (NY: MLSS - FinancialContent
Maxim Group Maintains Milestone Scientific(MLSS.US) With Buy Rating, Maintains Target Price $1 - Moomoo
Milestone Scientific Inc (MLSS) Q1 2026 Earnings Call Highlights: Strategic Growth Amid Global Challenges - GuruFocus
Milestone Scientific Earnings Call Signals Cautious Upswing - TipRanks
Milestone Scientific Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Earnings Call Summary | Milestone Scientific(MLSS.US) Q1 2026 Earnings Conference - Moomoo
MLSS Projects Strong Revenue Growth Through 2026 - GuruFocus
Earnings call transcript: Milestone Scientific Q1 2026 beats EPS expectations By Investing.com - Investing.com Nigeria
Earnings call transcript: Milestone Scientific Q1 2026 beats EPS expectations - Investing.com
Milestone Scientific (MLSS) Reports Q1 Revenue Challenges with P - GuruFocus
Full Transcript: Milestone Scientific Q1 2026 Earnings Call - Benzinga
Milestone Scientific stock surges 9% on narrower loss By Investing.com - Investing.com South Africa
Milestone Scientific Q1 revenue steady, operating loss narrows - TradingView
Milestone Scientific stock surges 9% on narrower loss - Investing.com UK
Milestone Scientific Reports Financial Results for First Quarter 2026 - marketscreener.com
Milestone Scientific Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2026 - marketscreener.com
Milestone Scientific Inc (MLSS) Q1 2026 Earnings Call Highlights: Strategic Growth Amid Global ... By GuruFocus - Investing.com Canada
Milestone Scientific earnings beat by $0.01, revenue fell short of estimates - Investing.com Canada
Milestone Scientific Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Milestone Scientific (MLSS) trims Q1 2026 loss but flags going concern and NYSE listing risks - Stock Titan
Milestone Scientific Schedules First Quarter 2026 Financial Results and Business Update Conference Call - Moomoo
Milestone Scientific will discuss Q1 results and business update May 14 - Stock Titan
Doctors in 7 states begin epidural procedures with CompuFlo - Stock Titan
Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption - The Manila Times
Milestone Scientific Inc. 2026 Stock Option Exchange, Incentive Plan, and Performance Sub-Plan Details - Minichart
Milestone Scientific Inc. Files Form 8-K Announcing Change in Auditor – May 2026 SEC Filing - Minichart
Milestone Scientific Restructures Executive Equity Incentive Programs - The Globe and Mail
Milestone Scientific appoints Grassi & Co. as new auditor, dismisses CBIZ CPAs - Investing.com Nigeria
Milestone Scientific approves stock option repricing and new performance-based awards - Investing.com
Milestone Scientific | 8-K: Current report - Moomoo
Auditor switch at Milestone Scientific (NYSE: MLSS) after going concern note - Stock Titan
Milestone Scientific (NYSE: MLSS) reprices options and grants 11.2M performance RSUs - Stock Titan
Milestone Scientific Inc. Files Amendment No. 1 to 2025 Annual Report (Form 10-K/A) with SEC - Minichart
[10-K/A] MILESTONE SCIENTIFIC INC. Amends Annual Report - Stock Titan
MLSS Milestone Scientific beats Q4 2025 loss estimates by 15 percent, shares drop 4.88 percent today.Crowd Breakout Signals - Newser
JPMorgan Active Bond ETF declares monthly distribution of $0.1936 - MSN
Milestone Scientific | D: Filing D - Moomoo
MLSS (Milestone Scientific Inc.) reports narrower Q4 2025 loss than estimates, but shares drop 6.9% in today's trading.Trending Entry Points - Cổng thông tin điện tử tỉnh Tây Ninh
Ballard (BLDP) Business Model Review | Ballard Power Systems Inc. posts 25.3% EPS surprise with narrower lossExpansion Phase - Cổng thông tin điện tử tỉnh Lào Cai
Milestone Scientific Completes Private Placement to Strengthen Finances - The Globe and Mail
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Unusual volume stocks are being observed in Tuesday's session. - ChartMill
Milestone Scientific Inc. Announces $2.15 Million Private Placement to Support Commercial Growth and Strengthen Balance Sheet 12 - Minichart
Milestone Scientific Inc. Stock (MLSS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):